<i>FKBP5</i> downregulation reduced tumor aggressiveness in KYSE70 cells, and clinical samples showed significantly worse survival rates in patients with high <i>FKBP5</i> expression (OS: P=0.02; RFS: P=0.04). Here, FKBP5 is linked to neoplasm.